NCT03880045 is a NA clinical trial of Topical TA in Myoma, sponsored by Aswan University Hospital.

Who is sponsoring NCT03880045?

NCT03880045 is sponsored by Aswan University Hospital.

What drugs are being tested in NCT03880045?

Interventions in NCT03880045: Topical TA, vasopressin, placebo to TA.

Is NCT03880045 still recruiting?

NCT03880045 is currently status unknown. Last updated 13 May 2019.

Last reviewed 2019-05-13 · How we verify

NCT03880045

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Topical Tranexamic Acid Plus Perivascular Vasopressin at the Time of Abdominal Myomectomy

Status unknown NA Last updated 13 May 2019

What this trial tests

NA trial testing Topical TA in Myoma in 100 participants. Status unknown.

Timeline

1 April 2019

Primary endpoint
30 March 2021

1 June 2021

Quick facts

Lead sponsor	Aswan University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	100
Start date	1 April 2019
Primary completion	30 March 2021
Estimated completion	1 June 2021
Sites	1 location across Egypt

Drugs / interventions tested

Topical TA — full drug profile →
vasopressin — full drug profile →
placebo to TA — full drug profile →

Conditions studied

Myoma — all drugs for Myoma →

Sponsor

Aswan University Hospital

Who can join

Adults 20 to 45, female only, with Myoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators will investigate the effectiveness of a topical tranexamic acid plus perivascular vasopressin compared with perivascular vasopressin alone for the reduction of blood loss at the time of myomectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myoma

Currently open trials in the same condition.

NCT05170230 — The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic · NA · recruiting
NCT05266534 — The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myome · NA · recruiting

Other Aswan University Hospital trials

Trials by the same sponsor.

NCT06491394 — Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats · Phase 4 · completed
NCT06211088 — Famotidine Versus Placebo in Emergency Pediatric Surgery As a Risk to Postoperative Nausea and Vomiting · NA · completed
NCT06583590 — Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction · Phase 2, PHASE3 · recruiting
NCT06537323 — Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl · NA · recruiting
NCT06535256 — Compare Intraperitoneal Instillation of Bupivacaine+dexmedetomidine Versus Bupivacaine+dexamethasone on Postoperative Pa · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03880045 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aswan University Hospital
Last refreshed: 13 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03880045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing